查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1718286

化療設備市場按產品類型、方式、應用和最終用戶分類－2025-2030 年全球預測

Chemotherapy Device Market by Product Type, Modality, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

化療設備市場預計到 2024 年將達到 203 億美元，到 2025 年將達到 217.4 億美元，到 2030 年將達到 309.4 億美元，複合年成長率為 7.27%。

主要市場統計數據
基準年2024年 203億美元
預計2025年 217.4億美元
預測年份 2030 309.4億美元
複合年成長率（%） 7.27%

在當今快速發展的醫療保健領域，化療設備市場正在經歷顯著的轉變，這得益於患者照護的不斷創新和改進。該報告深入探討了人們對先進化療設備日益成長的偏好背後的因素，並強調了精準治療和提高患者舒適度的重點。本摘要對關鍵產業趨勢、技術突破以及影響市場的動態法規環境進行了深入分析。癌症發病率的上升和對個人化醫療解決方案日益成長的需求正在促使各機構重新思考和重塑治療方法。本報告向相關人員提供了全面的說明，說明對有效、患者友善的治療方法日益成長的需求如何影響尖端化療設備的開發和可用性。

這個市場是由大量研發投資推動的，其結果是，生產的設備不僅技術先進，而且設計用於支援更高的臨床準確性和安全性。本介紹性概述為深入了解市場的各個方面奠定了基礎，並邀請行業專家和決策者共同探索化療設備領域當前和未來策略的關鍵因素。

改變化療設備市場

化療設備市場的演變是由改變傳統治療模式的轉型轉變所推動的。如今，醫療技術的進步以及研究機構和製造商之間的策略聯盟正在為創新創造肥沃的環境。這種演變的特徵是從傳統的一刀切治療方法轉變為滿足個別患者需求的個人化、適應性治療方案。

這項轉變的核心是數位技術和數據分析的整合，以提高設備性能的準確性和可靠性。小型化技術創新為高效且便攜的設備鋪平了道路，使臨床醫生能夠在各種環境中進行治療。此外，設計和功能的不斷改進正在減少與設備相關的併發症，並促進下一代治療方法的採用。

這些變化反映了以價值為基礎的醫療照護的更廣泛趨勢，這種模式強調改善結果、提高成本效益和提高病患滿意度。這些發展正在改變治療方式並創建一個更動態和靈活的醫療保健系統。這種轉變得到了監管變化的支持，監管變化越來越重視創新，同時確保病人安全，有助於為市場成長創造強勁的環境。透過這種綜合進步，該行業能夠更好地應對未來醫療保健需求的挑戰，更加靈活和精準。

設備市場的詳細細分洞察

對市場的徹底研究揭示了分層細分策略，這對於理解化療設備的不同方面至關重要。產品類型分析涵蓋導管、植入式端口、輸液幫浦、無針連接器等重要部分。值得注意的是，導管部分分為中央靜脈導管、周邊導管和周邊置入中央靜脈導管，並透過不同的、細緻的鏡頭進行檢查。同樣，輸液泵類別也擴展到攜帶型幫浦、彈性泵、注射式幫浦和容積泵等子區隔。如此詳細的產品分類有助於滿足特定患者的需求並改善臨床結果，並體現了製造商對精準和創新的承諾。

基於模態的細分區分了可攜式和固定式設備，進一步豐富了市場分析。此分類強調了旨在解決各種臨床情況的技術進步，從急性干預到受控環境中的常規長期護理。設備的便攜性尤其重要，因為它影響治療的可及性和便利性，進而直接影響患者的依從性和舒適度。

細分的另一個重要方面是基於用途。它涵蓋了各種癌症的治療通訊協定，包括乳癌、結腸癌、白血病、肺癌和前列腺癌。每種癌症類型都有其獨特的臨床挑戰和治療方法，需要根據其特定的醫學和解剖要求量身定做的設備。應用分析強調了設計設備的重要性，該設備不僅支援準確的藥物管理，而且還能在整個治療週期中促進安全有效的患者照護。

此外，我們還根據最終用戶進行細分，方面突顯了使用化療設備的醫療環境的多樣性。從門診手術中心到居家照護機構再到醫院，這些設備的使用適用於各種醫療保健服務模式。每個最終用戶類別都有獨特的操作需求和臨床期望，要求設備兼具效率和強大的安全功能。這種細分框架使製造商和醫療保健提供者能夠根據每個醫療保健環境的特定需求量身定做他們的產品，從而實現更加以患者為中心的方法。

這些細分見解的整合提供了對市場的全面了解。每個部分都有自己的子類別和特定的臨床應用，在推動創新化療設備的整體採用和成功方面發揮關鍵作用。對產品類型、模式、應用和最終用戶的細緻解讀凸顯了市場的複雜程度以及行業相關人員面臨的廣泛機會。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球癌症發生率和診斷率正在上升
      • 增加醫療成本以改善獲得先進醫療治療的機會
      • 個人化和標靶治療方法的重要性日益增加
    • 限制因素
      • 先進化療設備的高成本和替代治療技術的可用性
    • 機會
      • 標靶化療輸送系統開發的創新
      • 在化療設備中整合人工智慧和機器學習
    • 任務
      • 化療設備安全問題與潛在副作用
  • 市場區隔分析
    • 產品類型：易於插入和微創性推動了對周邊導管的需求
    • 最終用戶：化療設備擴大被應用於門診手術中心，以支持微創手術
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

第6章化療設備市場（依產品類型）

  • 導管
    • 中央靜脈導管
    • 周邊導管
    • 周邊置入中央靜脈導管
  • 凹陷端口
  • 點滴幫浦
    • 行人泵浦
    • 彈性體泵
    • 注射式幫浦
    • 正排量泵
  • 無針頭連接器

第7章化療設備市場：按方式

  • 行動裝置
  • 固定設備

第8章化療設備市場：依應用

  • 乳癌
  • 大腸直腸癌
  • 白血病
  • 肺癌
  • 攝護腺癌

第9章化療設備市場（按最終用戶）

  • 門診手術中心
  • 居家照護環境
  • 醫院

第10章美洲化療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第 11 章亞太化療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

12.歐洲、中東和非洲化療設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • AngioDynamics, Inc.
  • Avanos Medical, Inc.
  • B. Braun SE
  • Baxter International,
  • Becton, Dickinson and Company
  • Belmont Medical, Inc.
  • CODAN Medizinische Gerate GmbH
  • Districlass Medical SA
  • F. Hoffmann-La Roche Ltd
  • ICU Medical, Inc.
  • InfuSystems, Inc.
  • Leventon SAU
  • Micrel Medical Devices SA
  • Mindray Medical International Limited
  • Moog Inc.
  • Nipro Corporation
  • Omnicell Inc.
  • Poly Medicure Limited
  • Schiller AG
  • Smiths Group plc.
  • Terumo Corporation
  • ThermaSolutions
  • Ypsomed AG
  • Zyno Medical LLC.
Product Code: MRR-3204321AF6C6

The Chemotherapy Device Market was valued at USD 20.30 billion in 2024 and is projected to grow to USD 21.74 billion in 2025, with a CAGR of 7.27%, reaching USD 30.94 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 20.30 billion
Estimated Year [2025] USD 21.74 billion
Forecast Year [2030] USD 30.94 billion
CAGR (%) 7.27%

In today's rapidly evolving healthcare landscape, the chemotherapy device market is experiencing a noteworthy transformation driven by relentless innovation and enhanced patient care imperatives. This report delves into the drivers behind the growing preference for advanced chemotherapy devices, spotlighting the increased focus on precision treatment and improved patient comfort. In-depth analysis in this summary uncovers key industry trends, technological breakthroughs, and the dynamic regulatory environment that is shaping the market. With rising cancer incidence and increasing demand for personalized healthcare solutions, organizations are rethinking and reinventing their therapeutic methods. This report provides stakeholders with a comprehensive narrative that outlines how the growing need for effective, patient-friendly treatments is catalyzing the development and adoption of state-of-the-art chemotherapy devices.

The market is marked by significant investments in research and development, leading to devices that are not only technologically advanced but also engineered to support greater clinical precision and enhanced safety profiles. This introductory overview sets the stage for an insightful journey into the various facets of the market, encouraging both industry experts and decision-makers to explore key factors that are directing current and future strategies in the chemotherapy device sector.

Transformative Shifts in the Medical Landscape

The evolution of the chemotherapy device market is driven by transformative shifts that are altering the conventional treatment paradigms. Today, advancements in medical technology - along with strategic collaborations between research institutions and manufacturers - have created a fertile environment for innovation. This evolution is characterized by a move from conventional, one-size-fits-all treatment regimens to personalized, adaptive approaches that meet the individual requirements of patients.

At the heart of this shift is the integration of digital technologies and data analytics, enhancing the precision and reliability of device performance. Innovations in miniaturization have paved the way for devices that are not only highly efficient but also portable, empowering clinicians to administer care in diverse settings. Furthermore, continuous improvements in design and functionality have resulted in reduced complications associated with device usage, thereby promoting greater adoption of next-generation treatment modalities.

These changes reflect the broader trend toward value-based care - a model that emphasizes improved outcomes, cost efficiency, and enhanced patient satisfaction. Together, these developments are witnessing a transformation in how treatments are delivered, creating a more dynamic and responsive healthcare system. The shift is supported by regulatory changes that increasingly prioritize innovation while ensuring patient safety, contributing to a robust environment for market growth. Through such integrative advancements, the industry is prepared to meet the challenges of tomorrow's healthcare demands with agility and informed precision.

In-Depth Segmentation Insights of the Device Market

A thorough examination of the market reveals a layered segmentation strategy that is crucial to understanding the diverse aspects of chemotherapy devices. When analyzing product type, the exploration encompasses critical segments such as catheters, implantable ports, infusion pumps, and needleless connectors. Notably, the catheter segment is examined through a nuanced lens by dissecting it into central venous catheters, peripheral catheters, and peripherally inserted central catheters. Similarly, the infusion pump category is expanded into sub-segments including ambulatory pumps, elastomeric pumps, syringe pumps, and volumetric pumps. This detailed product categorization is instrumental in addressing specific patient needs as well as improving clinical outcomes, demonstrating the commitment of manufacturers to precision and innovation.

The segmentation based on modality further enriches the market analysis, differentiating between portable devices and stationary devices. This classification highlights the technological advancements aimed at meeting diverse clinical situations, ranging from emergency interventions to routine long-term therapies in controlled environments. The extent of device portability is particularly significant as it influences the accessibility and convenience of treatments, thereby directly impacting patient adherence and comfort.

Another critical dimension of segmentation is based on application. Here, the market scrutiny extends to treatment protocols for various types of cancers, including breast cancer, colorectal cancer, leukemia, lung cancer, and prostate cancer. Each cancer type has unique clinical challenges and treatment approaches, requiring devices that are tailored to the specific medical and anatomical requirements. The analysis of applications underscores the importance of designing devices that not only support precise drug administration but also facilitate safe and efficient patient care throughout the treatment cycle.

Further segmentation focuses on the end user, an aspect that highlights the diversity in medical settings where chemotherapy devices are deployed. From ambulatory surgical centers to homecare settings and hospitals, the use of these devices adapts to varied healthcare delivery models. Each end user category presents its own operational needs and clinical expectations, demanding devices that blend efficiency with robust safety features. This segmentation framework allows manufacturers and healthcare providers to align their product offerings with the detailed demands of each healthcare setting, resulting in a more patient centric approach.

The integration of these segmentation insights provides a comprehensive view of the market. Each segment, with its unique sub-categories and specific clinical applications, plays a pivotal role in advancing the overall adoption and success of innovative chemotherapy devices. The nuanced interpretation of product type, modality, application, and end user highlights the market's sophistication and the broad spectrum of opportunities that lie ahead for industry stakeholders.

Based on Product Type, market is studied across Catheters, Implantable Ports, Infusion Pumps, and Needleless Connectors. The Catheters is further studied across Central Venous Catheters, Peripheral Catheters, and Peripherally Inserted Central Catheters. The Infusion Pumps is further studied across Ambulatory Pumps, Elastomeric Pumps, Syringe Pumps, and Volumetric Pumps.

Based on Modality, market is studied across Portable Devices and Stationary Devices.

Based on Application, market is studied across Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, and Prostate Cancer.

Based on End User, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals.

Dynamic Regional Expansion Analysis

Geographic expansion remains a pivotal element of the market's growth, with significant opportunities emerging across various regions. A comprehensive regional analysis reveals that market dynamics vary considerably across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the focus on advanced healthcare infrastructure and the progressive integration of cutting-edge treatment practices continue to drive the adoption of innovative chemotherapy devices. This region's commitment to improving patient outcomes is also reflected in the strategic investments in digital health technologies and state-of-the-art medical equipment.

Europe, Middle East & Africa, on the other hand, present a diverse landscape marked by varying levels of healthcare infrastructure development. While some countries in Europe lean into established, highly regulated ecosystems, emerging economies in the Middle East and Africa are simultaneously catching up by investing in modern medical technologies. These regions are witnessing a transformation propelled by proactive policy measures and a growing emphasis on healthcare accessibility, ultimately paving the way for a broader adoption of sophisticated chemotherapy devices.

Lastly, the Asia-Pacific region stands out for its dynamic growth trajectory, supported by rapid technological advancements and increasing government initiatives aimed at modernizing healthcare delivery. In this region, the dual forces of a burgeoning patient population and rising awareness of innovative treatment solutions are fuelling market adoption. The diverse regulatory conditions and tailored healthcare models in Asia-Pacific further underscore the potential for significant market expansion, making it a focal area for device deployment strategies on a global scale.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Analysis

Navigating the competitive landscape involves a detailed examination of key industry players who are driving innovation and setting new standards in the development of chemotherapy devices. Leading companies in this space include those with longstanding industry presence as well as emerging innovators that continue to set benchmarks for quality and innovation. Established organizations such as AngioDynamics, Inc. and Avanos Medical, Inc. have played a pivotal role in integrating state-of-the-art technologies into their product lines, ensuring that their devices meet stringent safety and performance criteria. Other multinationals, including B. Braun SE, Baxter International, and Becton, Dickinson and Company, have consistently demonstrated robust innovation pipelines and a strong commitment to patient-centric healthcare solutions. These companies, alongside Belmont Medical, Inc. and CODAN Medizinische Gerate GmbH, continue to fortify the market with their technological advancements.

The competitive landscape is further enriched by players like Districlass Medical SA and F. Hoffmann-La Roche Ltd, whose efforts in R&D have driven significant enhancements in device efficacy and reliability. ICU Medical, Inc. and InfuSystems, Inc. have also contributed by expanding the range of available solutions, ensuring that the market is well-equipped to address the increasing complexity of cancer treatments. Firms such as Leventon S.A.U. and Micrel Medical Devices SA are gaining traction by focusing on niche segments, while Mindray Medical International Limited and Moog Inc. offer comprehensive device portfolios that cater to diverse clinical scenarios.

A noteworthy aspect of the market's competitive dynamics is the interplay between global leaders and regional innovators. Companies like Nipro Corporation, Omnicell Inc., and Poly Medicure Limited have made significant strides by tailoring their product offerings to meet localized demands. Additional contributions from Schiller AG, Smiths Group plc., Terumo Corporation, and ThermaSolutions enhance the market's depth by providing a wide array of technical solutions that are characterized by precision and operational effectiveness. Ypsomed AG and Zyno Medical LLC round out this competitive analysis by continuing to challenge industry norms and enhance device functionalities, thereby ensuring a continually evolving marketplace that is driven by patient needs, clinical demands, and technological breakthroughs.

The report delves into recent significant developments in the Chemotherapy Device Market, highlighting leading vendors and their innovative profiles. These include AngioDynamics, Inc., Avanos Medical, Inc., B. Braun SE, Baxter International,, Becton, Dickinson and Company, Belmont Medical, Inc., CODAN Medizinische Gerate GmbH, Districlass Medical SA, F. Hoffmann-La Roche Ltd, ICU Medical, Inc., InfuSystems, Inc., Leventon S.A.U., Micrel Medical Devices SA, Mindray Medical International Limited, Moog Inc., Nipro Corporation, Omnicell Inc., Poly Medicure Limited, Schiller AG, Smiths Group plc., Terumo Corporation, ThermaSolutions, Ypsomed AG, and Zyno Medical LLC.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to take strategic steps to ensure sustainable growth and to secure a competitive edge in this evolving market. First and foremost, continuous investment in research and development is critical to advancing device technologies that are both innovative and aligned with evolving clinical requirements. Leaders should focus on establishing robust collaborations that harness the power of interdisciplinary research, thereby fostering an environment where patient-centric solutions can be developed with precision and efficiency.

It is advisable for decision-makers to adopt a segmented approach that carefully considers the specific requirements of different product types, modalities, applications, and end users. Understanding the nuances of each market segment allows for the tailoring of solutions that address unique clinical challenges while optimizing patient outcomes. This strategic segmentation should guide product development as well as marketing and distribution strategies, ensuring that offerings are well-aligned with current industry needs.

Moreover, stakeholders should focus on geographic diversification as a growth lever. Expanding market presence across regions with varying levels of healthcare maturity and infrastructural advancements - such as the Americas, Europe, Middle East & Africa, and Asia-Pacific - can help to mitigate risks associated with market saturation in one particular area. Expanding into emerging markets where regulatory landscapes are evolving rapidly also presents an opportunity to capture early market share.

Additionally, in-depth competitor analysis remains a crucial component of strategic planning. Regularly monitoring the advancements made by industry leaders and innovators can provide insights that not only refine product offerings but also reveal emerging technological trends. Embracing competitive intelligence ensures that industry leaders can stay abreast of market movements, anticipate changes, and proactively adjust strategies to maintain a leadership position.

Finally, integrating feedback loops from clinical end users and frontline practitioners will further enable the refinement of existing devices and the development of innovative solutions that address real-world challenges. This iterative approach to product enhancement, coupled with a robust digital strategy for data analytics and market forecasting, will empower industry leaders to respond swiftly to market trends and patient needs. By adopting these strategic recommendations, stakeholders can drive innovation, optimize operational efficiency, and ensure a resilient market position in this dynamic landscape.

Conclusion: Strategic Direction for Market Success

The analysis presented in this report underscores a fundamental truth: the chemotherapy device market is undergoing a profound transformation, driven by a dedication to innovation, precision, and patient-centered care. The multi-faceted segmentation based on product types, modalities, applications, and end users has revealed the intricacies of a market that is both diverse and complex, yet unified by the goal of enhancing patient outcomes.

Regional dynamics further highlight opportunities for growth across various geographical areas, with regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific each offering unique challenges and opportunities. This global perspective reinforces the importance of navigating local nuances while leveraging global best practices. Meanwhile, the competitive landscape, marked by the contributions of leading and innovative companies, demonstrates that a commitment to technological excellence and patient safety is paramount in driving market success.

As the healthcare industry continues to shift towards value-based care, this report emphasizes that sustained investment in R&D, strategic market segmentation, active geographic expansion, and continuous competitive intelligence are critical strategies for future growth. The collaboration between clinicians, device manufacturers, and policy makers is vital in driving the development of devices that not only respond to the escalating demands of cancer therapies but also set new standards in clinical excellence.

In summary, this comprehensive overview serves as both a diagnostic and prognostic tool for industry leaders, capturing the current state of the market while providing a forward-looking blueprint for sustained growth and competitive differentiation. The strategic insights compiled herein empower stakeholders to make informed decisions that align with the rapidly changing dynamics of the healthcare sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of cancer and expanding diagnosis rates globally
      • 5.1.1.2. Rising healthcare expenditure for better access to advanced medical treatments
      • 5.1.1.3. Growing emphasis on personalized and targeted therapy approaches
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced chemotherapy devices and availability of alternative treatment technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in the development of targeted chemotherapy delivery systems
      • 5.1.3.2. Integration of artificial intelligence and machine learning in chemotherapy devices
    • 5.1.4. Challenges
      • 5.1.4.1. Safety concerns and potential adverse side effects of chemotherapy devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product Type: Rising demand for peripheral catheters owing to the ease of insertion and minimal invasiveness
    • 5.2.2. End User: Growing usage of chemotherapy devices in ambulatory surgical centers to support minimally invasive procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Chemotherapy Device Market, by Product Type

  • 6.1. Introduction
  • 6.2. Catheters
    • 6.2.1. Central Venous Catheters
    • 6.2.2. Peripheral Catheters
    • 6.2.3. Peripherally Inserted Central Catheters
  • 6.3. Implantable Ports
  • 6.4. Infusion Pumps
    • 6.4.1. Ambulatory Pumps
    • 6.4.2. Elastomeric Pumps
    • 6.4.3. Syringe Pumps
    • 6.4.4. Volumetric Pumps
  • 6.5. Needleless Connectors

7. Chemotherapy Device Market, by Modality

  • 7.1. Introduction
  • 7.2. Portable Devices
  • 7.3. Stationary Devices

8. Chemotherapy Device Market, by Application

  • 8.1. Introduction
  • 8.2. Breast Cancer
  • 8.3. Colorectal Cancer
  • 8.4. Leukemia
  • 8.5. Lung Cancer
  • 8.6. Prostate Cancer

9. Chemotherapy Device Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Chemotherapy Device Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Chemotherapy Device Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Chemotherapy Device Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Novocure received FDA approval of Optune Lua wearable tumor-zapping device transforms lung cancer treatment
    • 13.3.2. Luminate Medical secures USD 15 million Series A funding
    • 13.3.3. InfuSystem and Sanara MedTech secure exclusive U.S. distribution and joint venture rights for the ChemoMouthpiece oral cryotherapy device
    • 13.3.4. The merger between MOC and HOC-Vedanta enhances India's cancer treatment with advanced chemotherapy devices
    • 13.3.5. MIT-founded launched an innovative device for non-invasive monitoring of chemotherapy patients
    • 13.3.6. Advent International and Warburg Pincus acquired Baxter's Biopharma Solutions
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AngioDynamics, Inc.
  • 2. Avanos Medical, Inc.
  • 3. B. Braun SE
  • 4. Baxter International,
  • 5. Becton, Dickinson and Company
  • 6. Belmont Medical, Inc.
  • 7. CODAN Medizinische Gerate GmbH
  • 8. Districlass Medical SA
  • 9. F. Hoffmann-La Roche Ltd
  • 10. ICU Medical, Inc.
  • 11. InfuSystems, Inc.
  • 12. Leventon S.A.U.
  • 13. Micrel Medical Devices SA
  • 14. Mindray Medical International Limited
  • 15. Moog Inc.
  • 16. Nipro Corporation
  • 17. Omnicell Inc.
  • 18. Poly Medicure Limited
  • 19. Schiller AG
  • 20. Smiths Group plc.
  • 21. Terumo Corporation
  • 22. ThermaSolutions
  • 23. Ypsomed AG
  • 24. Zyno Medical LLC.

LIST OF FIGURES

  • FIGURE 1. CHEMOTHERAPY DEVICE MARKET MULTI-CURRENCY
  • FIGURE 2. CHEMOTHERAPY DEVICE MARKET MULTI-LANGUAGE
  • FIGURE 3. CHEMOTHERAPY DEVICE MARKET RESEARCH PROCESS
  • FIGURE 4. CHEMOTHERAPY DEVICE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. CHEMOTHERAPY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. CHEMOTHERAPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CHEMOTHERAPY DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CHEMOTHERAPY DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PERIPHERAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY IMPLANTABLE PORTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY AMBULATORY PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY NEEDLELESS CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CHEMOTHERAPY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CHEMOTHERAPY DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CHEMOTHERAPY DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 284. CHEMOTHERAPY DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 285. CHEMOTHERAPY DEVICE MARKET, FPNV POSITIONING MATRIX, 2024